Evidence map›Paper›PMID 29054423›Full record

ReviewAdvances in cancer research2017

Selenoproteins and Metastasis.

Michael P Marciel, Peter R Hoffmann

Registry-linked trialAbstract readReview
In one paragraph

Review in Advances in cancer research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05817227 (Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05817227 recruitingnot on this mapstarted 2022, after this paper: background citation

Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.

TypeobservationalSponsorNational Cancer Institute, NaplesRan2022 to 2027Enrolled300ConditionsBreast Cancer
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Antitumor Effects of Selenium.International journal of molecular sciences · 2021
    Review
  8. Review
  9. Nrf2 in Cancer, Detoxifying Enzymes and Cell Death Programs.Antioxidants (Basel, Switzerland) · 2021
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Selenoproteins in colon cancer.Free radical biology & medicine · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Michael P MarcielJohn A. Burns School of Medicine, University of Hawaii, Honolulu, HI, United States.
Peter R HoffmannJohn A. Burns School of Medicine, University of Hawaii, Honolulu, HI, United States. Electronic address: peterrh@hawaii.edu.
University of Hawaiʻi at Mānoa · US

Funding

Selenoprotein K modulates calcium-dependent signaling in immune cellsR01AI089999 · NIAID · UNIVERSITY OF HAWAII AT MANOA · PI HOFFMANN, PETER R · 2010 to 2020
$3.6M
NIAID NIH HHS R01 AI089999
6 · The paper itself

Abstract

Cancer survival is largely impacted by the dissemination of cancer cells from the original tumor site to secondary tissues or organs through metastasis. Targets for antimetastatic therapies have recently become a focus of research, but progress will require a better understanding of the molecular mechanisms driving metastasis. Selenoproteins play important roles in many of the cellular activities underlying metastasis including cell adhesion, matrix degradation and migration, invasion into the blood and extravasation into secondary tissues, and subsequent proliferation into metastatic tumors along with the angiogenesis required for growth. In this review the roles identified for different selenoproteins in these steps and how they may promote or inhibit metastatic cancers is discussed. These roles include selenoenzyme modulation of redox tone and detoxification of reactive oxygen species, calcium homeostasis and unfolded protein responses regulated by endoplasmic reticulum selenoproteins, and the multiple physiological responses influenced by other selenoproteins.

Indexed as

AnimalsEndoplasmic ReticulumHumansNeoplasm MetastasisNeoplasmsNeovascularization, PathologicOxidation-ReductionReactive Oxygen SpeciesSelenoproteinsReactive Oxygen SpeciesSelenoproteinsAngiogenesisAntioxidantCalcium fluxCancerMigrationRedoxSelenium

Identifiers

PMID29054423
PMCPMC6150923
OpenAlexW2752301594

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.